Effect of Pancreas Tonic (an Ayurvedic herbal supplement) in type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 53, Issue 9, 2004, Pages 1166-1173

  Hsia, Stanley H ^a   Bazargan, Mohsen ^a   Davidson, Mayer B ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEGLE MARMELOSE EXTRACT; AYURVEDIC DRUG; AZADIRACHTA INDICA EXTRACT; CINNAMONUM TAMALA EXTRACT; FICUS RACEMOSA EXTRACT; GYMNEMA SYLVESTRE EXTRACT; HEMOGLOBIN A1C; KINO EXTRACT; LIPID; METFORMIN; MOMORDICA CHARANTIA EXTRACT; PANCREAS TONIC; PLANT EXTRACT; SULFONYLUREA; SYZIGIUM CUMINI EXTRACT; TINOSPORA CORDIFOLIA EXTRACT; TRIGONELLA FOENUM GRAECUM EXTRACT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; EYE IRRITATION; FEMALE; FLANK PAIN; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; HEADACHE; HERB; HUMAN; HYPOGLYCEMIA; INSOMNIA; INSULIN SENSITIVITY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MUSCLE WEAKNESS; NIGHTMARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OTALGIA; PARESTHESIA; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SORE THROAT; STATISTICAL SIGNIFICANCE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICINE, AYURVEDIC; METFORMIN; MIDDLE AGED; PHYTOTHERAPY; QUALITY OF LIFE; SULFONYLUREA COMPOUNDS; TREATMENT OUTCOME;

EID: 4344627040     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.04.007     Document Type: Article

References (27)

1. American Diabetes Association. Facts & Figures. 2003;. Available at: http://www.diabetes.org/main/info/facts/facts_natl.jsp Accessed September
2. Carter J.S., Pugh J.A., Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med. 125:1996;221-232
3. Davidson M.B. Diabetes care in health maintenance organisation and fee-for-service settings. Dis Manage Health Outcomes. 2:1997;189-197
4. Eisenberg D.M., Kessler R.C., Foster C., et al. Unconventional medicine in the United States Prevalence, costs, and patterns of use. N Engl J Med. 328:1993;246-252
5. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997. JAMA. 280:1998;1569-1575
6. Yeh G.Y., Eisenberg D.M., Kaptchuk T.J., et al. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 26:2003;1277-1294
7. Angell M., Kassirer J.P. Alternative medicine - The risks of untested and unregulated remedies. N Engl J Med. 339:1998;839-841
8. Grover J.K., Yadav S., Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol. 81:2002;81-100
9. Kar A., Choudhary B.K., Bandyopadhyay N.G. Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. J Ethnopharmacol. 84:2003;105-108
10. Indian Council Medical Research (ICMR) Collaborating Centres, New Delhi. Flexible dose open trial of Vijayasar in cases of newly-diagnosed non-insulin-dependent diabetes mellitus. Indian J Med Res. 108:1998;24-29
11. Basch E., Gabardi S., Ulbricht C. Bitter melon (Momordica charantia) A review of efficacy and safety. Am J Health Syst Pharm. 60:2003;356-359
12. Welihinda J., Karunanayake E.H., Sheriff M.H., et al. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol. 17:1986;277-282
13. Shanmugasundaram E.R., Rajeswari G., Baskaran K., et al. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus. J Ethnopharmacol. 30:1990;281-294
14. Baskaran K., Kizar Ahamath B., et al. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J Ethnopharmacol. 30:1990;295-300
15. Ali L., Azad Khan A.K., Hassan Z., et al. Characterization of the hypoglycemic effects of Trigonella foenum graecum seed. Planta Med. 61:1995;358-360
16. Puri D., Prabhu K.M., Murthy P.S. Mechanism of action of a hypoglycemic principle isolated from fenugreek seeds. Indian J Physiol Pharmacol. 46:2002;457-462
17. Sharma R.D., Raghuram T.C., Rao N.S. Effect of fenugreek seeds on blood glucose and serum lipids in type I diabetes. Eur J Clin Nutr. 44:1990;301-306
18. Gupta A., Gupta R., Lal B. Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus A double blind placebo controlled study. J Assoc Physicians India. 49:2001;1057-1061
19. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502
20. Stewart A.L., Greenfield S., Hays R.D., et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA. 262:1989;907-913
21. Bergman R.N., Ider Y.Z., Bowden C.R., et al. Quantitative estimation of insulin sensitivity. Am J Physiol. 236:1979;E667-E677
22. DeFronzo R.A., Goodman A.M. the Multicenter Metformin Study Group. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 333:1995;541-549
23. Baron A., Neumann C. the PROTECT Study Group. PROTECT interim results A large multicenter study of patients with type II diabetes. Precose resolution of optimal titration to enhance current therapies. Clin Ther. 19:1997;282-295
24. Saad M.F., Anderson R.L., Laws A., et al. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance Insulin Resistance Atherosclerosis Study. Diabetes. 43:1994;1114-1121
25. Steil G.M., Murray J., Bergman R.N., et al. Repeatability of insulin sensitivity and glucose effectiveness from the minimal model Implications for study design. Diabetes. 43:1994;1365-1371
26. Ward W.K., Bolgiano D.C., McKnight B., et al. Diminished β-cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest. 74:1984;1318-1328
27. Ko G.T., Chan J.C., Woo L.J., et al. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem. 35:(Pt 1):1998;62-67